Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 4Terminated 2Unknown 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 70Breast Neoplasms 51Ovarian Neoplasms 43Lung Neoplasms 24Neoplasms 21Neoplasm Metastasis 20Fallopian Tube Neoplasms 20Carcinoma, Ovarian Epithelial 18Triple Negative Breast Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Uterine Cervical Neoplasms 9Head and Neck Neoplasms 9Stomach Neoplasms 8Recurrence 8Endometrial Neoplasms 8Adenocarcinoma of Lung 8Melanoma 7Esophageal Neoplasms 6Urinary Bladder Neoplasms 5Pancreatic Neoplasms 5Uterine Neoplasms 4Solid Tumors 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Adenocarcinoma Of Esophagus 4Thoracic Neoplasms 3Testicular Neoplasms 3Solid Tumor 3Sarcoma 3

Interventions

Radiotherapy 6Cisplatin 3Paclitaxel 2Carboplatin 2Amifostine 2Sodium Chloride 1Selenomethionine 1Radiation Dose Hypofractionation 1Radiation 1Neck Dissection 1Mental Status and Dementia Tests 1Lovastatin 1Lithium Carbonate 1Lithium 1Linseed Oil 1Glutamine 1G(M1) Ganglioside 1Fibroblast Growth Factor 7 1Electroacupuncture 1Diet Therapy 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Radiation Injuries × Paclitaxel × Clear all
NCT00618917 2021-11-12

MnSOD

University of Pittsburgh

Phase 1/2 Terminated
18 enrolled 12 charts
Thoracic

Lung Neoplasms, Radiation Injuries

NCT00025298 2012-09-24

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
5 enrolled
Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡